Proteomic characterization of neuromelanin granules isolated from human substantia nigra by laser-microdissection

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Plum, Sarah ^a   Steinbach, Simone ^a   Attems, Johannes ^b   Keers, Sharon ^b   Riederer, Peter ^c   Gerlach, Manfred ^c   May, Caroline ^a   Marcus, Katrin ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MELANIN; NERVE PROTEIN; NEUROMELANIN; PROTEOME;

CELL GRANULE; CYTOLOGY; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; LASER CAPTURE MICRODISSECTION; MALE; METABOLISM; PROCEDURES; PROTEOMICS; SUBSTANTIA NIGRA;

CYTOPLASMIC GRANULES; DOPAMINERGIC NEURONS; FEMALE; HUMANS; LASER CAPTURE MICRODISSECTION; MALE; MELANINS; NERVE TISSUE PROTEINS; PROTEOME; PROTEOMICS; SUBSTANTIA NIGRA;

EID: 84995428248     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep37139     Document Type: Article

References (37)

1. Tribl, F. et al. "Subcellular proteomics" of neuromelanin granules isolated from the human brain. Molecular & Cellular Proteomics 4, 945-957, doi: 10.1074/mcp.M400117-MCP200 (2005).
2. Fedorow, H. et al. Evidence for specific phases in the development of human neuromelanin. Neurobiology of Aging 27, 506-512, doi: 10.1016/j.neurobiolaging.2005.02.015 (2006).
3. Halliday, G. M. et al. Evidence for specific phases in the development of human neuromelanin. Journal of Neural Transmission 113, 721-728, doi: 10.1007/s00702-006-0449-y (2006).
4. Zecca, L. et al. Interaction of human substantia nigra neuromelanin with lipids and peptides. Journal of Neurochemistry 74, 1758-1765, doi: 10.1046/j.1471-4159.2000.0741758.x (2000).
5. Zecca, L. et al. The protective and toxic role of neuromelanins in brain aging and Parkinson's disease. Springerplus 4 (2015).
6. Shamoto-Nagai, M. et al. Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome. Journal of Neural Transmission 113, 633-644, doi: 10.1007/s00702-005-0410-5 (2006).
7. Shamoto-Nagai, M. et al. Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells. Journal of Neural Transmission 111, 1253-1265, doi: 10.1007/s00702-004-0211-2 (2004).
8. Beach, T. G. et al. Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits. Acta Neuropathologica 114, 419-424, doi: 10.1007/s00401-007-0250-5 (2007).
9. Oberländer, U. et al. Neuromelanin is an immune stimulator for dendritic cells in vitro. Bmc Neuroscience 12, 9, doi: 10.1186/1471-2202-12-116 (2011).
10. Zhang, W. et al. Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson's Disease. Neurotoxicity Research 19, 63-72, doi: 10.1007/s12640-009-9140-z (2011).
11. Hirsch, E., Graybiel, A. M. & Agid, Y. A. Melanized dopaminergic-neurons are differentially susceptible to degeneration in parkinsons-disease. Nature 334, 345-348, doi: 10.1038/334345a0 (1988).
12. Marsden, C. D. Pigmentation in nucleus substantiae nigrae of mammals. Journal of Anatomy 95, 256-& (1961).
13. Licker, V. et al. Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesis. Proteomics 14, 784-794, doi: 10.1002/pmic.201300342 (2014).
14. Plum, S. et al. Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis. Journal of proteomics 94, 202-206, doi: 10.1016/j.jprot.2013.07.015 (2013).
15. Molina, M. et al. Enrichment of single neurons and defined brain regions from human brain tissue samples for subsequent proteome analysis. Journal of Neural Transmission 122, 993-1005, doi: 10.1007/s00702-015-1414-4 (2015).
16. Vizcaino, J. A. et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Research 44, D447-D456, doi: 10.1093/nar/gkv1145 (2016).
17. Kley, R. A. et al. A Combined Laser Microdissection and Mass Spectrometry Approach Reveals New Disease Relevant Proteins Accumulating in Aggregates of Filaminopathy Patients. Molecular & Cellular Proteomics 12, 215-227, doi: 10.1074/mcp. M112.023176 (2013).
18. Uszkoreit, J. et al. PIA - An intuitive protein inference engine with a web-based user interface. Journal of Proteome Research, doi: 10.1021/acs.jproteome.5b00121 (2015).
19. Tribl, F. et al. Identification of L-ferritin in Neuromelanin Granules of the Human Substantia Nigra a Targeted Proteomics Approach. Molecular & Cellular Proteomics 8, 1832-1838, doi: 10.1074/mcp.M900006-MCP200 (2009).
20. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research 37, 1-13, doi: 10.1093/nar/gkn923 (2009).
21. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 4, 44-57, doi: 10.1038/nprot.2008.211 (2009).
22. R: A language and environment for statistical computing (R Foundation for Statistical Computing, Vienna, Austria, 2016).
23. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B-Methodological 57, 289-300 (1995).
24. Mouledous, L. et al. Lack of compatibility of histological staining methods with proteomic analysis of laser-capture microdissected brain samples. Journal of biomolecular techniques : JBT 13, 258-264 (2002).
25. Craven, R. A., Totty, N., Harnden, P., Selby, P. J. & Banks, R. E. Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis - Evaluation of tissue preparation and sample limitations. American Journal of Pathology 160, 815-822, doi: 10.1016/s0002-9440(10)64904-8 (2002).
26. Fedorow, H. et al. Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease. Progress in Neurobiology 75, 109-124, doi: 10.1016/j.pneurobio.2005.02.001 (2005).
27. Sulzer, D. et al. Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proceedings of the National Academy of Sciences of the United States of America 97, 11869-11874, doi: 10.1073/pnas.97.22.11869 (2000).
28. Zecca, L. et al. Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour. Journal of Clinical Pathology-Molecular Pathology 54, 414-418 (2001).
29. Dzierzega-Lecznar, A. et al. GC/MS analysis of thermally degraded neuromelanin from the human substantia nigra. Journal of the American Society for Mass Spectrometry 15, 920-926, doi: 10.1016/s1044-0305(04)00182-5 (2004).
30. Tribl, F., Arzberger, T., Riederer, P. & Gerlach, M. Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis. J Neural Transm Suppl, 51-55 (2007).
31. Ikemoto, K. et al. Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra? Neurosci Lett 253, 198-200 (1998).
32. Leverenz, J. B. et al. Proteomic identification of novel proteins in cortical Lewy bodies. Brain Pathology 17, 139-145, doi: 10.1111/j.1750-3639.2007.00048.x (2007).
33. Xia, Q. et al. Proteomic identification of novel proteins associated with Lewy bodies. Frontiers in bioscience : a journal and virtual library 13, 3850-3856 (2008).
34. Liao, L. et al. Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. The Journal of biological chemistry 279, 37061-37068, doi: 10.1074/jbc.M403672200 (2004).
35. Schroder, R. Comparative investigation of specific gravity of peritumoral brain-tissue in man. Acta Neurochirurgica 28, 341-351, doi: 10.1007/bf01405652 (1973).
36. Double, K. L. et al. Anti-melanin antibodies are increased in sera in Parkinson's disease. Experimental Neurology 217, 297-301, doi: 10.1016/j.expneurol.2009.03.002 (2009).
37. Tribl, F. et al. Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle. J Neural Transm 113, 741-749, doi: 10.1007/s00702-006-0452-3 (2006).